Simplify Asset Management Inc. acquired a new stake in shares of Cypherpunk Technologies (NASDAQ:CYPH – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,872,322 shares of the company’s stock, valued at approximately $2,172,000. Simplify Asset Management Inc. owned 4.52% of Cypherpunk Technologies at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in CYPH. Acadian Asset Management LLC lifted its position in Cypherpunk Technologies by 470.4% during the first quarter. Acadian Asset Management LLC now owns 1,280,531 shares of the company’s stock valued at $389,000 after buying an additional 1,056,047 shares during the period. Key Client Fiduciary Advisors LLC purchased a new position in Cypherpunk Technologies during the fourth quarter valued at $98,000. HighTower Advisors LLC purchased a new position in Cypherpunk Technologies during the fourth quarter valued at $59,000. Finally, Sequoia Financial Advisors LLC purchased a new position in Cypherpunk Technologies during the fourth quarter valued at $56,000. Hedge funds and other institutional investors own 30.46% of the company’s stock.
Analyst Upgrades and Downgrades
CYPH has been the subject of several recent research reports. Weiss Ratings lowered Cypherpunk Technologies from a “sell (d+)” rating to a “sell (d-)” rating in a research report on Thursday. Wall Street Zen lowered Cypherpunk Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, May 16th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Cypherpunk Technologies has an average rating of “Sell”.
Cypherpunk Technologies Price Performance
CYPH opened at $1.20 on Monday. Cypherpunk Technologies has a 1 year low of $0.23 and a 1 year high of $3.70. The stock has a 50-day moving average price of $0.90 and a 200-day moving average price of $1.02. The firm has a market cap of $127.75 million, a PE ratio of -59.97 and a beta of -0.09.
Cypherpunk Technologies (NASDAQ:CYPH – Get Free Report) last released its quarterly earnings data on Monday, May 18th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.42).
Cypherpunk Technologies Company Profile
Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.
DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.
Further Reading
- Five stocks we like better than Cypherpunk Technologies
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding CYPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cypherpunk Technologies (NASDAQ:CYPH – Free Report).
Receive News & Ratings for Cypherpunk Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cypherpunk Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
